HRP20050182A2 - Aqueous 2,6-diisopropylphenol pharmaceutical compositions - Google Patents
Aqueous 2,6-diisopropylphenol pharmaceutical compositionsInfo
- Publication number
- HRP20050182A2 HRP20050182A2 HR20050182A HRP20050182A HRP20050182A2 HR P20050182 A2 HRP20050182 A2 HR P20050182A2 HR 20050182 A HR20050182 A HR 20050182A HR P20050182 A HRP20050182 A HR P20050182A HR P20050182 A2 HRP20050182 A2 HR P20050182A2
- Authority
- HR
- Croatia
- Prior art keywords
- diisopropylphenol
- pharmaceutical compositions
- aqueous
- propofol
- present
- Prior art date
Links
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229960004134 propofol Drugs 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39949002P | 2002-07-29 | 2002-07-29 | |
US42219502P | 2002-10-29 | 2002-10-29 | |
US43697902P | 2002-12-30 | 2002-12-30 | |
US46245003P | 2003-04-11 | 2003-04-11 | |
US46431403P | 2003-04-21 | 2003-04-21 | |
US47040303P | 2003-05-14 | 2003-05-14 | |
US48535403P | 2003-07-07 | 2003-07-07 | |
PCT/US2003/023512 WO2004010941A2 (en) | 2002-07-29 | 2003-07-29 | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20050182A2 true HRP20050182A2 (en) | 2006-11-30 |
Family
ID=31192580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20050182A HRP20050182A2 (en) | 2002-07-29 | 2005-02-24 | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
Country Status (15)
Country | Link |
---|---|
US (1) | US7915317B2 (xx) |
EP (1) | EP1539122B1 (xx) |
JP (3) | JP2005538191A (xx) |
KR (1) | KR101145692B1 (xx) |
CN (1) | CN100438861C (xx) |
AU (1) | AU2003261274C1 (xx) |
BR (1) | BR0313060A (xx) |
CA (1) | CA2494297C (xx) |
HK (1) | HK1077515A1 (xx) |
HR (1) | HRP20050182A2 (xx) |
MX (1) | MXPA05001061A (xx) |
NZ (1) | NZ538255A (xx) |
PL (1) | PL375874A1 (xx) |
RS (1) | RS54275B1 (xx) |
WO (1) | WO2004010941A2 (xx) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040220283A1 (en) * | 2002-07-29 | 2004-11-04 | Transform Pharmaceuticals, Inc. | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
NZ538255A (en) | 2002-07-29 | 2006-11-30 | Transform Pharmaceuticals Inc | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
US7550155B2 (en) * | 2002-07-29 | 2009-06-23 | Transform Pharmaceuticals Inc. | Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses |
AU2003286725B2 (en) * | 2002-10-29 | 2007-07-12 | Transform Pharmaceuticals, Inc. | Propofol with cysteine |
US20040225022A1 (en) * | 2003-05-09 | 2004-11-11 | Desai Neil P. | Propofol formulation containing reduced oil and surfactants |
TR201802446T4 (tr) | 2004-05-19 | 2018-03-21 | Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct | Sodyum deoksikolat içeren enjeksiyonluk bileşim. |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
US7754230B2 (en) | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
DE102004045622A1 (de) * | 2004-09-17 | 2006-03-30 | Aquanova German Solubilisate Technologies (Agt) Gmbh | Konservierungsmittel-Zusammensetzungen |
WO2007128866A2 (en) * | 2006-05-09 | 2007-11-15 | Novobion Oy | Novel chemical compositions |
US8197499B2 (en) * | 2006-06-21 | 2012-06-12 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
US8608760B2 (en) * | 2006-06-21 | 2013-12-17 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
AU2007260924A1 (en) * | 2006-06-21 | 2007-12-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
US20090022727A1 (en) | 2007-01-26 | 2009-01-22 | Alza Corp. | Injectable, nonaqueous suspension with high concentration of therapeutic agent |
CA2710002A1 (en) * | 2007-12-20 | 2009-07-09 | Tautona Group, L.P. | Compositions and methods for joining non-conjoined lumens |
JP2011512346A (ja) | 2008-02-15 | 2011-04-21 | ノボビオン オイ | クルクミンの可溶性錯体 |
US8563037B2 (en) * | 2009-02-06 | 2013-10-22 | Tautona Group, L.P. | Compositions and methods for joining non-conjoined lumens |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
MX2012011262A (es) | 2010-04-01 | 2013-02-11 | Pharmanest Ab | Composiciones anestesicas termogelificantes. |
WO2012047870A2 (en) * | 2010-10-05 | 2012-04-12 | The Medicines Company | Antimicrobial preservation of propofol emulsions |
US8658676B2 (en) | 2010-10-12 | 2014-02-25 | The Medicines Company | Clevidipine emulsion formulations containing antimicrobial agents |
EP2627173B2 (en) * | 2010-10-12 | 2018-07-04 | Chiesi Farmaceutici S.p.A. | Clevidipine emulsion formulations containing antimicrobial agents |
WO2012112940A1 (en) | 2011-02-18 | 2012-08-23 | Kythera Biopharmaceuticals, Inc. | Treatment of submental fat |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
GB201106031D0 (en) | 2011-04-08 | 2011-05-25 | Highway Resource Solutions Ltd | Adaptions to a lantern |
EP3206683A4 (en) | 2014-10-16 | 2018-06-13 | The Board of Trustees of the Leland Stanford Junior University | Novel methods, compounds, and compositions for anesthesia |
CN114712308A (zh) * | 2015-12-09 | 2022-07-08 | 磷肌酸有限公司 | 药物制剂 |
MX2019006845A (es) | 2016-12-21 | 2019-10-15 | Avecho Biotechnology Ltd | Proceso. |
CN106581737B (zh) * | 2017-01-06 | 2019-09-06 | 哈尔滨鼓润生物技术有限公司 | 一种止血组合物及其制备方法 |
WO2018225229A1 (en) * | 2017-06-08 | 2018-12-13 | Terumo Kabushiki Kaisha | Parenteral aqueous pharmaceutical composition |
CN113905731A (zh) * | 2019-04-05 | 2022-01-07 | 索伦托药业有限公司 | 大麻二酚药物组合物 |
CN114601800B (zh) * | 2021-09-28 | 2023-07-28 | 天津瑞普生物技术股份有限公司 | 一种甲磷丙泊酚钠无菌粉针剂及其制备方法 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1472793A (en) * | 1974-03-28 | 1977-05-04 | Ici Ltd | Pharmaceutical compositions |
US4798846A (en) * | 1974-03-28 | 1989-01-17 | Imperial Chemical Industries Plc | Pharmaceutical compositions |
US5296161A (en) * | 1986-06-09 | 1994-03-22 | The Clorox Company | Enzymatic perhydrolysis system and method of use for bleaching |
DK0576612T3 (da) * | 1991-03-19 | 2000-05-22 | Cytrx Corp | Polyoxypropylen/polyoxyethylen-copolymerer med forbedret aktivitet |
US6277410B1 (en) * | 1992-10-08 | 2001-08-21 | Supratek Pharma Inc. | Copolymer compositions for oral delivery |
GB9405593D0 (en) | 1994-03-22 | 1994-05-11 | Zeneca Ltd | Pharmaceutical compositions |
US5731356A (en) * | 1994-03-22 | 1998-03-24 | Zeneca Limited | Pharmaceutical compositions of propofol and edetate |
US5635540A (en) * | 1994-12-09 | 1997-06-03 | The University Of Virginia Patent Foundation | Stabilized topical pharmaceutical preparations |
WO1997010814A1 (en) | 1995-09-18 | 1997-03-27 | Vesifact Ag | Propofol nanodispersions |
US6077545A (en) * | 1995-10-30 | 2000-06-20 | Matrix Pharmaceuticals, Inc. | Process and composition for therapeutic cisplatin (CDDP) |
US5637625A (en) * | 1996-03-19 | 1997-06-10 | Research Triangle Pharmaceuticals Ltd. | Propofol microdroplet formulations |
US20020107291A1 (en) * | 1997-05-26 | 2002-08-08 | Vincenzo De Tommaso | Clear, injectable formulation of an anesthetic compound |
US5962536A (en) | 1998-07-31 | 1999-10-05 | Komer; Gene | Injectable propofol formulations |
US7097849B2 (en) * | 1998-08-19 | 2006-08-29 | Jagotec Ag | Injectable aqueous dispersions of propofol |
US6150423A (en) * | 1998-10-15 | 2000-11-21 | Phoenix Scientific, Inc. | Propofol-based anesthetic and method of making same |
US6140373A (en) * | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
US6140374A (en) * | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
US6100302A (en) * | 1999-04-05 | 2000-08-08 | Baxter International Inc. | Propofol formulation with enhanced microbial characteristics |
US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
ATE327741T1 (de) * | 1999-06-21 | 2006-06-15 | Kuhnil Pharmaceutical Co Ltd | Propofol enthaltende anästhetische zusammensetzung zur intravenösen injektion |
GB2359747B (en) | 2000-02-29 | 2002-04-24 | Maelor Pharmaceuticals Ltd | Anaesthetic formulations |
WO2001089514A2 (en) | 2000-05-25 | 2001-11-29 | Astrazeneca Ab | Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent |
IL153457A0 (en) | 2000-06-16 | 2003-07-06 | Skyepharma Canada Inc | Improved injectable dispersions of propofol |
IN187686B (xx) | 2000-06-21 | 2002-06-08 | Bharat Serums & Vaccines Ltd | |
US6623765B1 (en) * | 2000-08-01 | 2003-09-23 | University Of Florida, Research Foundation, Incorporated | Microemulsion and micelle systems for solubilizing drugs |
IN188917B (xx) | 2000-12-07 | 2002-11-23 | Bharat Surums & Vaccines Ltd | |
JP4334229B2 (ja) | 2001-03-20 | 2009-09-30 | サイデックス・ファーマシューティカルズ・インコーポレイテッド | プロポフォール及びスルホアルキルエーテルシクロデキストリン含有製剤 |
US7034013B2 (en) * | 2001-03-20 | 2006-04-25 | Cydex, Inc. | Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
GB0120702D0 (en) | 2001-08-24 | 2001-10-17 | Maelor Pharmaceuticals Ltd | Anaesthetic formulations |
GB0124071D0 (en) | 2001-10-08 | 2001-11-28 | Kbig Ltd | Improvement in the administration of high boiling point aneasthetics |
NZ538255A (en) | 2002-07-29 | 2006-11-30 | Transform Pharmaceuticals Inc | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
US20040220283A1 (en) * | 2002-07-29 | 2004-11-04 | Transform Pharmaceuticals, Inc. | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
US7550155B2 (en) * | 2002-07-29 | 2009-06-23 | Transform Pharmaceuticals Inc. | Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses |
KR100482269B1 (ko) | 2002-10-08 | 2005-04-14 | 센츄론(주) | 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법 |
US8476010B2 (en) * | 2003-07-10 | 2013-07-02 | App Pharmaceuticals Llc | Propofol formulations with non-reactive container closures |
-
2003
- 2003-07-29 NZ NZ538255A patent/NZ538255A/en not_active IP Right Cessation
- 2003-07-29 RS YU20050066A patent/RS54275B1/sr unknown
- 2003-07-29 CN CNB038180758A patent/CN100438861C/zh not_active Expired - Fee Related
- 2003-07-29 WO PCT/US2003/023512 patent/WO2004010941A2/en active Application Filing
- 2003-07-29 KR KR1020057001649A patent/KR101145692B1/ko active IP Right Grant
- 2003-07-29 US US10/629,308 patent/US7915317B2/en not_active Expired - Fee Related
- 2003-07-29 EP EP03771951.5A patent/EP1539122B1/en not_active Expired - Lifetime
- 2003-07-29 CA CA2494297A patent/CA2494297C/en not_active Expired - Fee Related
- 2003-07-29 MX MXPA05001061A patent/MXPA05001061A/es active IP Right Grant
- 2003-07-29 AU AU2003261274A patent/AU2003261274C1/en not_active Ceased
- 2003-07-29 JP JP2005505627A patent/JP2005538191A/ja not_active Withdrawn
- 2003-07-29 PL PL03375874A patent/PL375874A1/xx unknown
- 2003-07-29 BR BR0313060-6A patent/BR0313060A/pt not_active Application Discontinuation
-
2005
- 2005-02-24 HR HR20050182A patent/HRP20050182A2/xx not_active Application Discontinuation
- 2005-11-28 HK HK05110804.0A patent/HK1077515A1/xx not_active IP Right Cessation
-
2010
- 2010-11-29 JP JP2010265559A patent/JP2011144161A/ja active Pending
-
2013
- 2013-11-29 JP JP2013248238A patent/JP2014058553A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1539122B1 (en) | 2014-01-29 |
RS54275B1 (sr) | 2016-02-29 |
CA2494297C (en) | 2011-10-18 |
AU2003261274A1 (en) | 2004-02-16 |
KR101145692B1 (ko) | 2012-05-25 |
JP2005538191A (ja) | 2005-12-15 |
JP2014058553A (ja) | 2014-04-03 |
NZ538255A (en) | 2006-11-30 |
US20050027019A1 (en) | 2005-02-03 |
AU2003261274C1 (en) | 2009-02-12 |
PL375874A1 (en) | 2005-12-12 |
CN100438861C (zh) | 2008-12-03 |
MXPA05001061A (es) | 2005-10-05 |
RS20050066A (xx) | 2007-09-21 |
WO2004010941A3 (en) | 2004-06-17 |
HK1077515A1 (en) | 2006-02-17 |
CN1671367A (zh) | 2005-09-21 |
CA2494297A1 (en) | 2004-02-05 |
EP1539122A4 (en) | 2010-03-10 |
JP2011144161A (ja) | 2011-07-28 |
WO2004010941A2 (en) | 2004-02-05 |
US7915317B2 (en) | 2011-03-29 |
BR0313060A (pt) | 2005-06-28 |
EP1539122A2 (en) | 2005-06-15 |
AU2003261274B2 (en) | 2008-07-31 |
KR20050026539A (ko) | 2005-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20050182A2 (en) | Aqueous 2,6-diisopropylphenol pharmaceutical compositions | |
ME00408B (me) | Preparati insulina koji ne sadrže cink ili sadrže male količine cinka koji imaju poboljšanu stabilnost | |
BRPI0415449A (pt) | combinações de compostos ativos fungicidas sinergìsticos | |
BRPI0515316A (pt) | compostos de imidazoquinolina | |
ATE229802T1 (de) | Zusammenstellung aus gemischten cyanoacrylatestern | |
BRPI0415758A (pt) | combinações de substáncias ativas fungicidas sinergìsticas | |
MX9306708A (es) | Composiciones de espuma de lucha contra el fuego, de un solvente polar de baja viscosidad. | |
MEP35108A (en) | Herbicidal composition | |
BRPI0412895A (pt) | combinações de substáncias ativas fungicidas | |
RS49764B (sr) | Farmaceutski preparat za primenu na mukozu | |
DE60110438D1 (de) | Zusammensetzungen enthaltend stilbenoide mit einer hypoglykämischen wirkung | |
CR9114A (es) | 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion | |
BRPI0412871A (pt) | combinações de substáncias ativas fungicidas | |
YU4197A (sh) | Smeše koje se mogu izolovati polazeći od semena eugenia jambolana lamarck, njihovo dobijanje i primena ovih smeša i nekih od njihovih sastojaka kao lekova | |
BR0113463A (pt) | Composição farmacêutica para o tratamento e/ou prevenção de infecções clamidiais, composição pró-saúde e seu uso | |
BR0304655A (pt) | Composições farmacêuticas de reepitelização compreendendo goma xantana | |
MXPA04001256A (es) | Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso. | |
BRPI0416787A (pt) | composições de limpeza de óleo natural do tipo formadoras de efeito sinalizador "blooming" | |
WO2004039326A3 (en) | Propofol with cysteine | |
GT200200249A (es) | Composicion herbicida | |
DE60136718D1 (de) | Hren zur herstellung | |
BR0311479A (pt) | Derivados de tiofeno antelmìnticos e inseticidas | |
BR0313751A (pt) | Heterociclilpirimidinas substituìdas | |
ATE412404T1 (de) | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon | |
YU44799A (xx) | Pesticidni 1-arilpirazoli |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20060712 Year of fee payment: 4 |
|
A1OB | Publication of a patent application | ||
OBST | Application withdrawn |